-
2
-
-
0028864049
-
Value of myoglobin, troponin T, and CK-MB mass in ruling out an acute myocardial infarction in the emergency room
-
de Winter RJ, Koster RW, Sturk A, et al. Value of myoglobin, troponin T, and CK-MB mass in ruling out an acute myocardial infarction in the emergency room. Circulation 1995;92:3401-7.
-
(1995)
Circulation
, vol.92
, pp. 3401-3407
-
-
De Winter, R.J.1
Koster, R.W.2
Sturk, A.3
-
3
-
-
0034672568
-
Comparison between strategies using creatinine kinase-MB (mass), myoglobin, and troponin T in the early detection or exclusion of acute myocardial infarction in patients with chest pain and a non-diagnostic electrocardiogram
-
A5
-
Jernberg T, Lindahl B, James S, et al. Comparison between strategies using creatinine kinase-MB (mass), myoglobin, and troponin T in the early detection or exclusion of acute myocardial infarction in patients with chest pain and a non-diagnostic electrocardiogram. Am J Cardiol. 2000;86:1367-71, A5.
-
(2000)
Am J Cardiol
, vol.86
, pp. 1367-1371
-
-
Jernberg, T.1
Lindahl, B.2
James, S.3
-
4
-
-
0033982084
-
Very early diagnosis and risk stratification of patients admitted with suspected acute myocardial infarction by the combined evaluation of a single serum value of cardiac troponin-T, myoglobin, and creatinine kinase MB (mass)
-
Jurlander B, Clemmensen P, Wagner GS, et al. Very early diagnosis and risk stratification of patients admitted with suspected acute myocardial infarction by the combined evaluation of a single serum value of cardiac troponin-T, myoglobin, and creatinine kinase MB (mass). Eur Heart J 2000;21:382-9.
-
(2000)
Eur Heart J
, vol.21
, pp. 382-389
-
-
Jurlander, B.1
Clemmensen, P.2
Wagner, G.S.3
-
5
-
-
0033851515
-
Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction
-
Alpert J, Thygesen K, Antman E, et al. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69.
-
(2000)
J Am Coll Cardiol
, vol.36
, pp. 959-969
-
-
Alpert, J.1
Thygesen, K.2
Antman, E.3
-
6
-
-
0034884193
-
The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: A meta-analysis
-
Heidenreich PA, Alloggiamento T, Melsop K, et al. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol 2001;38:478-85.
-
(2001)
J Am Coll Cardiol
, vol.38
, pp. 478-485
-
-
Heidenreich, P.A.1
Alloggiamento, T.2
Melsop, K.3
-
7
-
-
0037047095
-
Elevations in troponin T and I are associated with abnormal tissue level perfusion: A TACTICS-TIMI 18 substudy
-
Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction
-
Wong GC, Morrow DA, Murphy S, et al. Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction. Circulation 2002;106:202-7.
-
(2002)
Circulation
, vol.106
, pp. 202-207
-
-
Wong, G.C.1
Morrow, D.A.2
Murphy, S.3
-
8
-
-
0036569965
-
Intravascular ultrasound findings in patients with acute coronary syndromes with and without elevated troponin I level
-
Fuchs S, Stabile E, Mintz GS, et al. Intravascular ultrasound findings in patients with acute coronary syndromes with and without elevated troponin I level. Am J Cardiol 2002;89:1111-3.
-
(2002)
Am J Cardiol
, vol.89
, pp. 1111-1113
-
-
Fuchs, S.1
Stabile, E.2
Mintz, G.S.3
-
9
-
-
0033589739
-
Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban
-
PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management
-
Heeschen C, Hamm CW, Goldmann B, et al. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management. Lancet 1999;354:1757-62.
-
(1999)
Lancet
, vol.354
, pp. 1757-1762
-
-
Heeschen, C.1
Hamm, C.W.2
Goldmann, B.3
-
10
-
-
0035930101
-
Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: Results from a randomized trial
-
Morrow DA, Cannon CP, Rifai N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 2001;286:2405-12.
-
(2001)
JAMA
, vol.286
, pp. 2405-2412
-
-
Morrow, D.A.1
Cannon, C.P.2
Rifai, N.3
-
11
-
-
0034669458
-
Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: A TIMI-11B substudy
-
Morrow DA, Antman EM, Tanasijevic M, et al. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. J Am Coll Cardiol 2000;36:1812-7.
-
(2000)
J Am Coll Cardiol
, vol.36
, pp. 1812-1817
-
-
Morrow, D.A.1
Antman, E.M.2
Tanasijevic, M.3
-
12
-
-
17844391803
-
Narrative review: Alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded
-
Jeremias A, Gibson CM. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 2005;142:786-91.
-
(2005)
Ann Intern Med
, vol.142
, pp. 786-791
-
-
Jeremias, A.1
Gibson, C.M.2
-
13
-
-
0347593907
-
Prevalence of increased cardiac troponin I levels in patients with and without acute pulmonary embolism and relation of increased cardiac troponin I levels with in-hospital mortality in patients with acute pulmonary embolism
-
Yalamanchili K, Sukhija R, Aronow WS, et al. Prevalence of increased cardiac troponin I levels in patients with and without acute pulmonary embolism and relation of increased cardiac troponin I levels with in-hospital mortality in patients with acute pulmonary embolism. Am J Cardiol 2004;93:263-4.
-
(2004)
Am J Cardiol
, vol.93
, pp. 263-264
-
-
Yalamanchili, K.1
Sukhija, R.2
Aronow, W.S.3
-
14
-
-
0038263154
-
Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis
-
deFilippi C, Wasserman S, Rosanio S, et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 2003;290:353-9.
-
(2003)
JAMA
, vol.290
, pp. 353-359
-
-
DeFilippi, C.1
Wasserman, S.2
Rosanio, S.3
-
15
-
-
0037638743
-
Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes
-
Ammann P, Maggiorini M, Bertel O, et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003;41:2004-9.
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 2004-2009
-
-
Ammann, P.1
Maggiorini, M.2
Bertel, O.3
-
16
-
-
0037182780
-
Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction
-
Aviles RJ, Askari AT, Lindahl B, et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med 2002;346:2047-52.
-
(2002)
N Engl J Med
, vol.346
, pp. 2047-2052
-
-
Aviles, R.J.1
Askari, A.T.2
Lindahl, B.3
-
17
-
-
0037016006
-
Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease
-
Apple FS, Murakami MM, Pearce LA, et al. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002;106:2941-5.
-
(2002)
Circulation
, vol.106
, pp. 2941-2945
-
-
Apple, F.S.1
Murakami, M.M.2
Pearce, L.A.3
-
18
-
-
0042198675
-
B-type natriuretic peptide in cardiovascular disease
-
de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003;362:316-22.
-
(2003)
Lancet
, vol.362
, pp. 316-322
-
-
De Lemos, J.A.1
McGuire, D.K.2
Drazner, M.H.3
-
19
-
-
0029948712
-
Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide
-
Omland T, Aakvaag A, Bonarjee VV, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996;93:1963-9.
-
(1996)
Circulation
, vol.93
, pp. 1963-1969
-
-
Omland, T.1
Aakvaag, A.2
Bonarjee, V.V.3
-
20
-
-
0037130155
-
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure
-
Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7.
-
(2002)
N Engl J Med
, vol.347
, pp. 161-167
-
-
Maisel, A.S.1
Krishnaswamy, P.2
Nowak, R.M.3
-
21
-
-
15944365796
-
How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: Systematic review
-
Doust JA, Pietrzak E, Dobson A, et al. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 2005;330:625.
-
(2005)
BMJ
, vol.330
, pp. 625
-
-
Doust, J.A.1
Pietrzak, E.2
Dobson, A.3
-
22
-
-
0028300572
-
Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium
-
Toth M, Vuorinen KH, Vuolteenaho O, et al. Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium. Am J Physiol 1994;266:H1572-80.
-
(1994)
Am J Physiol
, vol.266
-
-
Toth, M.1
Vuorinen, K.H.2
Vuolteenaho, O.3
-
23
-
-
8144225341
-
Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia
-
Sabatine MS, Morrow DA, de Lemos JA, et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 2004;44:1988-95.
-
(2004)
J Am Coll Cardiol
, vol.44
, pp. 1988-1995
-
-
Sabatine, M.S.1
Morrow, D.A.2
De Lemos, J.A.3
-
24
-
-
0033806421
-
Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty
-
Tateishi J, Masutani M, Ohyanagi M, et al. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol 2000;23:776-80.
-
(2000)
Clin Cardiol
, vol.23
, pp. 776-780
-
-
Tateishi, J.1
Masutani, M.2
Ohyanagi, M.3
-
25
-
-
0036295245
-
Natriuretic peptide system gene expression in human coronary arteries
-
Casco VH, Veinot JP, Kuroski de Bold ML, et al. Natriuretic peptide system gene expression in human coronary arteries. J Histochem Cytochem 2002;50:799-809.
-
(2002)
J Histochem Cytochem
, vol.50
, pp. 799-809
-
-
Casco, V.H.1
Veinot, J.P.2
Kuroski De Bold, M.L.3
-
26
-
-
27144481572
-
Coronary Atherosclerosis and Plasma Levels of N-terminal Pro-Brain Natriuretic Peptide: Results from the Dallas Heart Study
-
Abdullah S, Khera A, Das S, et al. Coronary Atherosclerosis and Plasma Levels of N-terminal Pro-Brain Natriuretic Peptide: Results from the Dallas Heart Study. Am J Cardiol 2005;96:1284-9.
-
(2005)
Am J Cardiol
, vol.96
, pp. 1284-1289
-
-
Abdullah, S.1
Khera, A.2
Das, S.3
-
27
-
-
0027210868
-
Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction
-
Morita E, Yasue H, Yoshimura M, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993;88:82-91.
-
(1993)
Circulation
, vol.88
, pp. 82-91
-
-
Morita, E.1
Yasue, H.2
Yoshimura, M.3
-
28
-
-
0028135228
-
Relationship between plasma level of brain natriuretic peptide and myocardial infarct size
-
Arakawa N, Nakamura M, Aoki H, et al. Relationship between plasma level of brain natriuretic peptide and myocardial infarct size. Cardiology 1994;85:334-40.
-
(1994)
Cardiology
, vol.85
, pp. 334-340
-
-
Arakawa, N.1
Nakamura, M.2
Aoki, H.3
-
29
-
-
0031951028
-
Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction
-
Nagaya N, Nishikimi T, Goto Y, et al. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction. Am Heart J 1998;135:21-8.
-
(1998)
Am Heart J
, vol.135
, pp. 21-28
-
-
Nagaya, N.1
Nishikimi, T.2
Goto, Y.3
-
30
-
-
0035807597
-
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes
-
de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-21.
-
(2001)
N Engl J Med
, vol.345
, pp. 1014-1021
-
-
De Lemos, J.A.1
Morrow, D.A.2
Bentley, J.H.3
-
31
-
-
0037016035
-
N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes
-
Omland T, Persson A, Ng L, et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 2002;106:2913-8.
-
(2002)
Circulation
, vol.106
, pp. 2913-2918
-
-
Omland, T.1
Persson, A.2
Ng, L.3
-
32
-
-
0037083217
-
Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes
-
Omland T, de Lemos JA, Morrow DA, et al. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes. Am J Cardiol 2002;89:463-5.
-
(2002)
Am J Cardiol
, vol.89
, pp. 463-465
-
-
Omland, T.1
De Lemos, J.A.2
Morrow, D.A.3
-
33
-
-
0037036842
-
N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation
-
Jernberg T, Stridsberg M, Venge P, et al. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 2002;40:437-45.
-
(2002)
J Am Coll Cardiol
, vol.40
, pp. 437-445
-
-
Jernberg, T.1
Stridsberg, M.2
Venge, P.3
-
34
-
-
0344608881
-
Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18
-
Morrow DA, de Lemos JA, Sabatine MS, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol 2003;41:1264-72.
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 1264-1272
-
-
Morrow, D.A.1
De Lemos, J.A.2
Sabatine, M.S.3
-
35
-
-
28944439267
-
Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease
-
Morrow D, de Lemos J, Blazing M, et al. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. JAMA 2005;294:2866-71.
-
(2005)
JAMA
, vol.294
, pp. 2866-2871
-
-
Morrow, D.1
De Lemos, J.2
Blazing, M.3
-
36
-
-
0345047709
-
N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease
-
Jernberg T, Lindahl B, Siegbahn A, et al. N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease. J Am Coll Cardiol 2003;42:1909-16.
-
(2003)
J Am Coll Cardiol
, vol.42
, pp. 1909-1916
-
-
Jernberg, T.1
Lindahl, B.2
Siegbahn, A.3
-
38
-
-
0034704893
-
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
-
Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
-
(2000)
N Engl J Med
, vol.342
, pp. 836-843
-
-
Ridker, P.M.1
Hennekens, C.H.2
Buring, J.E.3
-
39
-
-
0037078969
-
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events
-
Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-65.
-
(2002)
N Engl J Med
, vol.347
, pp. 1557-1565
-
-
Ridker, P.M.1
Rifai, N.2
Rose, L.3
-
40
-
-
22844432451
-
Race and gender differences in C-reactive protein levels
-
Khera A, McGuire D, Murphy S, et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005;46:464-9.
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 464-469
-
-
Khera, A.1
McGuire, D.2
Murphy, S.3
-
41
-
-
1842587885
-
CRP and other circulating markers of inflammation in the prediction of chronic heart disease
-
Danesh J, Wheeler JG, Hirschfield G. CRP and other circulating markers of inflammation in the prediction of chronic heart disease. N Engl J Med 2004;350:1387-97.
-
(2004)
N Engl J Med
, vol.350
, pp. 1387-1397
-
-
Danesh, J.1
Wheeler, J.G.2
Hirschfield, G.3
-
42
-
-
0031746866
-
C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI 11A substudy. Thrombolysis in Myocardial Infarction
-
Morrow DA, Rifai N, Antman EM, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998;31:1460-5.
-
(1998)
J Am Coll Cardiol
, vol.31
, pp. 1460-1465
-
-
Morrow, D.A.1
Rifai, N.2
Antman, E.M.3
-
43
-
-
0034687438
-
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease
-
FRISC Study Group. Fragmin during Instability in Coronary Artery Disease
-
Lindahl B, Toss H, Siegbahn A, et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 2000;343:1139-47.
-
(2000)
N Engl J Med
, vol.343
, pp. 1139-1147
-
-
Lindahl, B.1
Toss, H.2
Siegbahn, A.3
-
44
-
-
0037454156
-
Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: A GUSTO-IV substudy
-
James SK, Armstrong P, Barnathan E, et al. Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy. J Am Coll Cardiol 2003;41:916-24.
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 916-924
-
-
James, S.K.1
Armstrong, P.2
Barnathan, E.3
-
45
-
-
0033020625
-
Human endothelium as a source of multifunctional cytokines: Molecular regulation and possible role in human disease
-
Krishnaswamy G, Kelley J, Yerra L, et al. Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res 1999;19:91-104.
-
(1999)
J Interferon Cytokine Res
, vol.19
, pp. 91-104
-
-
Krishnaswamy, G.1
Kelley, J.2
Yerra, L.3
-
46
-
-
0026075699
-
Monocyte chemoattractant protein-1 in human atheromatous plaques
-
Nelken NA, Coughlin SR, Gordon D, et al. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991;88:1121-7.
-
(1991)
J Clin Invest
, vol.88
, pp. 1121-1127
-
-
Nelken, N.A.1
Coughlin, S.R.2
Gordon, D.3
-
47
-
-
0025954705
-
Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions
-
Yla-Herttuala S, Lipton BA, Rosenfeld ME, et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A 1991;88:5252-6.
-
(1991)
Proc Natl Acad Sci U S A
, vol.88
, pp. 5252-5256
-
-
Yla-Herttuala, S.1
Lipton, B.A.2
Rosenfeld, M.E.3
-
48
-
-
0032134003
-
Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice
-
Gu L, Okada Y, Clinton SK, et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998;2:275-81.
-
(1998)
Mol Cell
, vol.2
, pp. 275-281
-
-
Gu, L.1
Okada, Y.2
Clinton, S.K.3
-
49
-
-
0033060017
-
Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice
-
Dawson TC, Kuziel WA, Osahar TA, et al. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 1999;143:205-11.
-
(1999)
Atherosclerosis
, vol.143
, pp. 205-211
-
-
Dawson, T.C.1
Kuziel, W.A.2
Osahar, T.A.3
-
50
-
-
0030586940
-
Platelet-derived growth factor-BB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor
-
Ernofsson M, Siegbahn A. Platelet-derived growth factor-BB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor. Thromb Res 1996;83:307-20.
-
(1996)
Thromb Res
, vol.83
, pp. 307-320
-
-
Ernofsson, M.1
Siegbahn, A.2
-
51
-
-
0032584250
-
Elevated circulating levels of C-C chemokines in patients with congestive heart failure
-
Aukrust P, Ueland T, Muller F, et al. Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation 1998;97:1136-43.
-
(1998)
Circulation
, vol.97
, pp. 1136-1143
-
-
Aukrust, P.1
Ueland, T.2
Muller, F.3
-
52
-
-
7044262896
-
Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis
-
Deo R, Khera A, McGuire DK, et al. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 2004;44:1812-8.
-
(2004)
J Am Coll Cardiol
, vol.44
, pp. 1812-1818
-
-
Deo, R.1
Khera, A.2
McGuire, D.K.3
-
53
-
-
0037432168
-
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes
-
de Lemos JA, Morrow DA, Sabatine MS, et al. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 2003;107:690-5.
-
(2003)
Circulation
, vol.107
, pp. 690-695
-
-
De Lemos, J.A.1
Morrow, D.A.2
Sabatine, M.S.3
-
54
-
-
0035045084
-
Suppression of nuclear factor-kappaB and stimulation of inhibitor kappaB by troglitazone: Evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese
-
Ghanim H, Garg R, Aljada A, et al. Suppression of nuclear factor-kappaB and stimulation of inhibitor kappaB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese. J Clin Endocrinol Metab 2001;86:1306-12.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 1306-1312
-
-
Ghanim, H.1
Garg, R.2
Aljada, A.3
-
55
-
-
0036066345
-
Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients
-
Rezaie-Majd A, Maca T, Bucek RA, et al. Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 2002;22:1194-9.
-
(2002)
Arterioscler Thromb Vasc Biol
, vol.22
, pp. 1194-1199
-
-
Rezaie-Majd, A.1
Maca, T.2
Bucek, R.A.3
-
56
-
-
0032729718
-
Red wine inhibits monocyte chemotactic protein-1 expression and modestly reduces neointimal hyperplasia after balloon injury in cholesterol-Fed rabbits
-
Feng AN, Chen YL, Chen YT, et al. Red wine inhibits monocyte chemotactic protein-1 expression and modestly reduces neointimal hyperplasia after balloon injury in cholesterol-Fed rabbits. Circulation 1999;100:2254-9.
-
(1999)
Circulation
, vol.100
, pp. 2254-2259
-
-
Feng, A.N.1
Chen, Y.L.2
Chen, Y.T.3
-
57
-
-
0031772830
-
ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis
-
Hernandez-Presa MA, Bustos C, Ortego M, et al. ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis. Am J Pathol 1998;153:1825-37.
-
(1998)
Am J Pathol
, vol.153
, pp. 1825-1837
-
-
Hernandez-Presa, M.A.1
Bustos, C.2
Ortego, M.3
-
58
-
-
0035824895
-
CD40 signaling and plaque instability
-
Schonbeck U, Libby P. CD40 signaling and plaque instability. Circ Res 2001;89:1092-103.
-
(2001)
Circ Res
, vol.89
, pp. 1092-1103
-
-
Schonbeck, U.1
Libby, P.2
-
59
-
-
0032484987
-
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
-
Henn V, Slupsky JR, Grafe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998;391:591-4.
-
(1998)
Nature
, vol.391
, pp. 591-594
-
-
Henn, V.1
Slupsky, J.R.2
Grafe, M.3
-
60
-
-
0037143597
-
Platelet-derived CD40L: The switch-hitting player of cardiovascular disease
-
Andre P, Nannizzi-Alaimo L, Prasad SK, et al. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 2002;106:896-9.
-
(2002)
Circulation
, vol.106
, pp. 896-899
-
-
Andre, P.1
Nannizzi-Alaimo, L.2
Prasad, S.K.3
-
61
-
-
0036130828
-
CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism
-
Andre P, Prasad KS, Denis CV, et al. CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med 2002;8:247-52.
-
(2002)
Nat Med
, vol.8
, pp. 247-252
-
-
Andre, P.1
Prasad, K.S.2
Denis, C.V.3
-
62
-
-
0344850187
-
Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes
-
Aukrust P, Muller F, Ueland T, et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 1999;100:614-20.
-
(1999)
Circulation
, vol.100
, pp. 614-620
-
-
Aukrust, P.1
Muller, F.2
Ueland, T.3
-
63
-
-
0035183844
-
Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets
-
Garlichs CD, Eskafi S, Raaz D, et al. Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets. Heart 2001;86:649-55.
-
(2001)
Heart
, vol.86
, pp. 649-655
-
-
Garlichs, C.D.1
Eskafi, S.2
Raaz, D.3
-
64
-
-
0037456769
-
Soluble CD40 ligand in acute coronary syndromes
-
Heeschen C, Dimmeler S, Hamm CW, et al. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003;348:1104-11.
-
(2003)
N Engl J Med
, vol.348
, pp. 1104-1111
-
-
Heeschen, C.1
Dimmeler, S.2
Hamm, C.W.3
-
65
-
-
0041315652
-
Soluble CD40L: Risk prediction after acute coronary syndromes
-
Varo N, de Lemos JA, Libby P, et al. Soluble CD40L: risk prediction after acute coronary syndromes. Circulation 2003;108:1049-52.
-
(2003)
Circulation
, vol.108
, pp. 1049-1052
-
-
Varo, N.1
De Lemos, J.A.2
Libby, P.3
-
66
-
-
0035824162
-
Association between myeloperoxidase levels and risk of coronary artery disease
-
Zhang R, Brennan ML, Fu X, et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001;286:2136-42.
-
(2001)
JAMA
, vol.286
, pp. 2136-2142
-
-
Zhang, R.1
Brennan, M.L.2
Fu, X.3
-
67
-
-
0142089171
-
Prognostic value of myeloperoxidase in patients with chest pain
-
Brennan ML, Penn MS, Van Lente F, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003;349:1595-604.
-
(2003)
N Engl J Med
, vol.349
, pp. 1595-1604
-
-
Brennan, M.L.1
Penn, M.S.2
Van Lente, F.3
-
68
-
-
0141727730
-
Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes
-
Baldus S, Heeschen C, Meinertz T, et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003;108:1440-5.
-
(2003)
Circulation
, vol.108
, pp. 1440-1445
-
-
Baldus, S.1
Heeschen, C.2
Meinertz, T.3
-
69
-
-
0037382477
-
The search for a biomarker of cardiac ischemia
-
Morrow DA, de Lemos JA, Sabatine MS, et al. The search for a biomarker of cardiac ischemia. Clin Chem 2003;49:537-9.
-
(2003)
Clin Chem
, vol.49
, pp. 537-539
-
-
Morrow, D.A.1
De Lemos, J.A.2
Sabatine, M.S.3
-
70
-
-
0038634588
-
Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: A preliminary comparison to creatinine kinase-MB, myoglobin, and troponin I
-
Bar-Or D, Winkler JV, Vanbenthuysen K, et al. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatinine kinase-MB, myoglobin, and troponin I. Am Heart J 2001;141:985-91.
-
(2001)
Am Heart J
, vol.141
, pp. 985-991
-
-
Bar-Or, D.1
Winkler, J.V.2
Vanbenthuysen, K.3
-
71
-
-
0037842058
-
Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention
-
Sinha MK, Gaze DC, Tippins JR, et al. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003;107:2403-5.
-
(2003)
Circulation
, vol.107
, pp. 2403-2405
-
-
Sinha, M.K.1
Gaze, D.C.2
Tippins, J.R.3
-
72
-
-
0042347516
-
Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia
-
Quiles J, Roy D, Gaze D, et al. Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia. Am J Cardiol 2003;92:322-4.
-
(2003)
Am J Cardiol
, vol.92
, pp. 322-324
-
-
Quiles, J.1
Roy, D.2
Gaze, D.3
-
73
-
-
0035106441
-
Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: A multicenter study
-
Christenson RH, Duh SH, Sanhai WR, et al. Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001;47:464-70.
-
(2001)
Clin Chem
, vol.47
, pp. 464-470
-
-
Christenson, R.H.1
Duh, S.H.2
Sanhai, W.R.3
-
74
-
-
11244302615
-
Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting
-
Anwaruddin S, Januzzi JL Jr, et al. Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. Am J Clin Pathol 2005;123:140-5.
-
(2005)
Am J Clin Pathol
, vol.123
, pp. 140-145
-
-
Anwaruddin, S.1
Januzzi Jr., J.L.2
-
75
-
-
0842308025
-
Role of "ischemia modified albumin", a new biochemical marker of myocardial ischemia, in the early diagnosis of acute coronary syndromes
-
Sinha MK, Roy D, Gaze DC, et al. Role of "ischemia modified albumin", a new biochemical marker of myocardial ischemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004;21:29-34.
-
(2004)
Emerg Med J
, vol.21
, pp. 29-34
-
-
Sinha, M.K.1
Roy, D.2
Gaze, D.C.3
-
76
-
-
21244443815
-
Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome
-
Worster A, Devereaux PJ, Heels-Ansdell D, et al. Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ 2005;172:1685-90.
-
(2005)
CMAJ
, vol.172
, pp. 1685-1690
-
-
Worster, A.1
Devereaux, P.J.2
Heels-Ansdell, D.3
-
77
-
-
20244384861
-
Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome
-
Apple FS, Wu AH, Mair J, et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005;51:810-24.
-
(2005)
Clin Chem
, vol.51
, pp. 810-824
-
-
Apple, F.S.1
Wu, A.H.2
Mair, J.3
-
78
-
-
5644278968
-
Proteomic analysis of plasma from patients during an acute coronary syndrome
-
Mateos-Caceres PJ, Garcia-Mendez A, Lopez Farre A, et al. Proteomic analysis of plasma from patients during an acute coronary syndrome. J Am Coll Cardiol 2004;44:1578-83.
-
(2004)
J Am Coll Cardiol
, vol.44
, pp. 1578-1583
-
-
Mateos-Caceres, P.J.1
Garcia-Mendez, A.2
Lopez Farre, A.3
-
79
-
-
0037117649
-
Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: Simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide
-
Sabatine MS, Morrow DA, de Lemos JA, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 2002;105:1760-3-3.
-
(2002)
Circulation
, vol.105
-
-
Sabatine, M.S.1
Morrow, D.A.2
De Lemos, J.A.3
|